Didanosine (2′,3′-dideoxyinosine, ddI, DDI) marketed under the trade names
Videx and Videx EC. It is an antiretroviral medication used to treat HIV/AIDS in ...
Didanosine can cause serious, life-threatening side effects. These include
pancreatitis (inflammation of the pancreas), lactic acidosis (buildup of lactic acid
in the ...
This modification prevents the formation of phosphodiester linkages which are
needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor
Physician reviewed didanosine patient information - includes didanosine
description, dosage and directions.
VIDEX (didanosine, USP) pediatric powder for oral solution. Initial U.S. Approval:
... women who received the combination of didanosine and stavudine. (5.2).
ddI (didanosine, Videx/VidexEC) is an anti-HIV drug that reduces the amount of
virus in the body. Anti-HIV drugs such as ddI slow down or prevent damage to ...
Didanosine was approved in 1991 as an antiretroviral drug (ARV) for people with
HIV infection. The generic version was approved in 2004. It has been studied ...
Find patient medical information for didanosine oral on WebMD including its uses
, side effects and safety, interactions, pictures, warnings and user ratings.
Jan 25, 2001 ... Approval. FDA approval of didanosine was granted in 1991 for adult and
pediatric use. Initial approval (for patients intolerant to, ...
Sep 1, 2015 ... Didanosine is used in combination with other medicines for the treatment of
human immunodeficiency virus (HIV) infection. HIV is the virus that ...